Clinical trial
Prialt (Ziconotide) In Severe Chronic Pain
NCT00047749 · Elan Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00047749 |
|---|---|
| Title | Prialt (Ziconotide) In Severe Chronic Pain |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults With Severe Chronic Pain |
| Lead sponsor | Elan Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Prialt (ziconotide) |
| Enrollment | 220 |
| Start date | Aug 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Oct 17, 2002 |
| Last update posted | Dec 14, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: